| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2541449 | International Immunopharmacology | 2010 | 4 Pages |
Abstract
These results suggest that serum M65 and M30 levels were elevated in patients with advanced gastric carcinoma patients. Serum M30 levels can be helpful to predict tumor load and also survival.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Emel Yaman, Ugur Coskun, Banu Sancak, Suleyman Buyukberber, Banu Ozturk, Mustafa Benekli,